SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Sokka T, Abelson B, Pincus T.Mortality in rheumatoid arthritis: 2008 update.Clin Exp Rheumatol2008;26:S3561.
  • 2
    Watson DJ, Rhodes T, Guess HA.All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database.J Rheumatol2003;30:1196202.
  • 3
    Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D.Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.Arthritis Rheum2008;59:16907.
  • 4
    Gabriel SE, Crowson CS, O'Fallon WM.Mortality in rheumatoid arthritis: have we made an impact in 4 decades?J Rheumatol1999;26:252933.
  • 5
    Radovits BJ, Fransen J, Al Shamma A, Eijsbouts AM, van Reil PL, Laan RF.Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis.Arthritis Care Res (Hoboken)2010;62:36270.
  • 6
    Mikuls TR, Saag KG, Criswell LA, Merlino LA, Kaslow RA, Shelton BJ, et al.Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study.Ann Rheum Dis2002;61:9949.
  • 7
    Bjornadal L, Baecklund E, Yin L, Granath F, Klareskog L, Ekbom A.Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort study in Sweden, 1964-95.J Rheumatol2002;29:90612.
  • 8
    Meune C, Touze E, Trinquart L, Allanore Y.High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis.Arch Cardiovasc Dis2010;103:25361.
  • 9
    Bergstrom U, Jacobsson LT, Turesson C.Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden.Rheumatology (Oxford)2009;48:16005.
  • 10
    Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM III, Therneau TM, et al.The widening mortality gap between rheumatoid arthritis patients and the general population.Arthritis Rheum2007;56:35837.
  • 11
    Jacobsson LT, Turesson C, Nilsson JA, Petersson IF, Lindqvist E, Saxne T, et al.Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis.Ann Rheum Dis2007;66:6705.
  • 12
    Mikuls TR, Fay BT, Michaud K, Sayles H, Thiele GM, Caplan L, et al.Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry.Rheumatology (Oxford)2011;50:1019.
  • 13
    Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, Choy E, et al.The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.Rheumatology (Oxford)2010;49:295307.
  • 14
    Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F.Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.Lancet2002;359:11737.
  • 15
    Pincus T, Sokka T, Wolfe F.Premature mortality in patients with rheumatoid arthritis: evolving concepts [editorial].Arthritis Rheum2001;44:12346.
  • 16
    Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van 't Hof M, et al.The prognostic value of anti– cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.Arthritis Rheum2000;43:18315.
  • 17
    Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW.Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.Arthritis Res Ther2005;7:R94958.
  • 18
    Sihvonen S, Korpela M, Mustila A, Mustonen J.The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis.J Rheumatol2005;32:208994.
  • 19
    Crowson CS, Liang KP, Therneau TM, Maradit Kremers H, Gabriel SE.Could accelerated aging explain the excess mortality in patients with seropositive rheumatoid arthritis?Arthritis Rheum2010;62:37882.
  • 20
    Davidson A, Diamond B.Autoimmune diseases.N Engl J Med2001;345:34050.
  • 21
    Pulendran B, Artis D.New paradigms in type 2 immunity.Science2012;337:4315.
  • 22
    Hueber W, Tomooka BH, Zhao X, Kidd BA, Drijfhout JW, Fries JF, et al.Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-CCP-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines.Ann Rheum Dis2007;66:7129.
  • 23
    Klareskog L, Catrina AI, Paget S.Rheumatoid arthritis.Lancet2009;373:65972.
  • 24
    Sihvonen S, Korpela M, Laippala P, Mustonen J, Pasternack A.Death rates and causes of death in patients with rheumatoid arthritis: a population-based study.Scand J Rheumatol2004;33:2217.
  • 25
    Liang KP, Gabriel SE.Autoantibodies: innocent bystander or key player in immunosenescence and atherosclerosis?J Rheumatol2007;34;12037.
  • 26
    Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al.Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.Arthritis Rheum2003;48:27419.
  • 27
    Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH.Anti–citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis [review].Arthritis Rheum2009;61:147283.
  • 28
    Wiik AS, van Venrooij WJ, Pruijn GJM.All you wanted to know about anti-CCP but were afraid to ask.Autoimmun Rev2010;10:903.
  • 29
    Walitt B, Mackey R, Kuller L, Deane KD, Robinson W, Holers VM, et al.Predictive value of autoantibody testing for validating self-reported diagnoses of rheumatoid arthritis in the Women's Health Initiative.Am J Epidemiol2013;177:88793.
  • 30
    Women's Health Initiative Study Group.Design of the Women's Health Initiative clinical trial and observational study.Control Clin Trials1998;19:61109.
  • 31
    Lynch CP, McTigue KM, Bost JE, Tinker LF, Vitolins M, Adams-Campbell L, et al.Excess weight and physical health-related quality of life in postmenopausal women of diverse racial/ethnic backgrounds.J Womens Health2010;19:144958.
  • 32
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum1988;31:31524.
  • 33
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al.The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum1982;25:12717.
  • 34
    McTigue KM, Chang YF, Eaton C, Garcia L, Johnson KC, Lewis CE, et al.Severe obesity, heart disease, and death among white, African-American, and Hispanic postmenopausal women.Obesity2012. E-pub ahead of print.
  • 35
    Eaton CB, Young A, Allison MA, Robinson J, Martin LW, Kuller LH, et al.Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women's Health Initiative (WHI).Am J Clin Nutr2011;94:14718.
  • 36
    Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, et al.Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.Arthritis Rheum2012;64:231927.
  • 37
    Ware JE Jr, Snow KK, Kosinski M, Gandek B.SF-36 health survey: manual and interpretation guide.Boston:The Health Institute, New England Medical Center;1993.
  • 38
    Padyukov L, Seieslastad M, Ong RT, Ding B, Ronnelid J, Seddighzadeh M, et al, and the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) Study Group.A genome- wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.Ann Rheum Dis2011;70:25965.
  • 39
    Greenberg JD, Kremer JM, Curtis JR, Hochberg MC, Reed G, Tsao P, et al, on behalf of the CORRONA Investigators.Tumour necrosis factor antagonist use associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.Ann Rheum Dis2011;70:57682.
  • 40
    Wasko MC, Dasgupta A, Hubert H, Fries JF, Ward MM.Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis [published erratum appears in Arthritis Rheum 2013;65:1231].Arthritis Rheum2013;65:33442.
  • 41
    Ridker PM.Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).J Thromb Haemost2009;7:3329.
  • 42
    Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al, for the INSIGHT SMART Study Group.Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.PLoS Med2008;5:e203.
  • 43
    Wynn TA, Ramalingam TR.Mechanisms of fibrosis: therapeutic translation for fibrotic disease.Nat Med2012;18:102840.
  • 44
    Sattar N, McCarey DW, Capell H, McInnes IB.Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis.Circulation2003;108:295763.
  • 45
    Connolly M, Mullan RH, McCormick J, Matthews C, Sullivan O, Kennedy A, et al.Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.Arthritis Rheum2012;64:103545.
  • 46
    Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, et al.Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med2012;185:6776.
  • 47
    Weyand CM, Fulbright JW, Goronzy JJ.Immunosenescence, autoimmunity, and rheumatoid arthritis.Exp Gerentol2003;38:83341.
  • 48
    Michel JJ, Turesson C, Lemster B, Atkins SR, Iclozan C, Bongartz T, et al.CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis.Arthritis Rheum2007;56:4357.
  • 49
    Fischer A, du Bois R.Interstitial lung disease in connective tissue disorders.Lancet2012;380:68998.
  • 50
    Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, et al.The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.Arthritis Rheum2005;52:41220.
  • 51
    Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, et al.Mortality in rheumatoid arthritis: increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis.Rheumatology (Oxford)2007;46:3507.
  • 52
    Falk RH, Comenzo RL, Skinner M.The systemic amyloidoses.N Engl J Med2007;337:898909.
  • 53
    Wong TC, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, et al.Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality.Circulation2012;126:120616.